Affimed N.V. (LON: 0HL9)
London
· Delayed Price · Currency is GBP · Price in USD
1.100
-0.049 (-4.26%)
Jan 22, 2025, 6:54 PM BST
Affimed Employees
Affimed had 76 employees as of December 30, 2023. The number of employees decreased by 143 or -65.30% compared to the previous year.
Employees
76
Change (1Y)
-143
Growth (1Y)
-65.30%
Revenue / Employee
61.72K GBP
Profits / Employee
-766.12K GBP
Market Cap
14.64M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Affimed News
- 5 weeks ago - Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC) - Benzinga
- 6 weeks ago - Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) - GlobeNewsWire
- 6 weeks ago - Affimed reports data from mid-stage study of its lymphoma treatment - Seeking Alpha
- 6 weeks ago - Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer - GlobeNewsWire
- 6 weeks ago - Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients - GlobeNewsWire
- 7 weeks ago - Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA) - GlobeNewsWire
- 2 months ago - Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Affimed Reports Third Quarter 2024 Financial Results & Business Update - GlobeNewsWire